Building Closer Friendships in Social Anxiety Disorder

January 26, 2021 updated by: Jesse Cougle, Florida State University

Building Closer Friendships in Social Anxiety Disorder: A Preliminary Test

This study assesses whether a 4-week computerized intervention can be used to decrease fear of intimacy, and loneliness and improve perceived social support in people with Social Anxiety Disorder.

Study Overview

Status

Completed

Conditions

Detailed Description

This study hopes to assess whether a month long computerized intervention aimed at giving people skills to form closer friendships. Participants will be randomized into an active treatment condition or a wait list control. We hypothesize that 1) participants in the treatment condition will have lower fear of intimacy at post treatment than those in the waitlist condition 2) participants in the treatment condition will have lower levels of loneliness than those in the waitlist condition 3) participants in the treatment condition will have higher perceived social support than those in the waitlist condition.

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tallahassee, Florida, United States, 32304
        • Florida State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Social Anxiety Disorder Diagnosed by the Mini International Neuropsychiatric Interview
  • Social Phobia Inventory Score >19
  • Stable psychotropic medication for the past month and kept stable for duration of study

Exclusion Criteria:

  • Currently participating in therapy
  • Current Substance Dependence
  • Bipolar Disorder or psychotic illness
  • Current suicidality (imminent risk)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active Treatment
four week computerized intervention designed to reduce fear of intimacy
Intervention designed to build social support and reduce loneliness by giving participants skills to strengthen their relationships
No Intervention: Wait List Control
Participants will continue as usual and will be given the option to receive the active treatment after completion of the study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Multidimensional Scale of Perceived Social Support
Time Frame: Change in Perceived Social Support from baseline to post treatment (4weeks) and one month follow up (8 weeks)
Self-report scale that measures perceived levels of social support. Scores range from 12 to 84 with higher scores indicating higher levels of perceived social support. The three subscales (friends, family and significant other) all have a range of 4 to 28 with higher scores indicating higher levels of perceived social support.
Change in Perceived Social Support from baseline to post treatment (4weeks) and one month follow up (8 weeks)
Fear of Intimacy Scale-friend version
Time Frame: Change in fear of intimacy from baseline to post treatment (4weeks) and one month follow up (8 weeks)
self report scale measuring fear of intimacy in friendships. Scores range from 26 to 130 with higher scores indicating a higher level of fear of intimacy.
Change in fear of intimacy from baseline to post treatment (4weeks) and one month follow up (8 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
UCLA Loneliness Scale
Time Frame: Change in loneliness from baseline to post treatment (4weeks) and one month follow up (8 weeks)
A 20 item Self report scale measuring loneliness. Scales range from 0 to 60 with higher scores indicating a higher level of loneliness.
Change in loneliness from baseline to post treatment (4weeks) and one month follow up (8 weeks)
Social Phobia inventory
Time Frame: Change in social anxiety symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks)
Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.
Change in social anxiety symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks)
State-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T)
Time Frame: Change in overall anxiety symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks)
Self-report measure used to assess overall anxiety symptoms. Scores range from 21 to 84 with higher scores indicating higher levels of overall anxiety.
Change in overall anxiety symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks)
Center for Epidemiological Studies Depression Scale (CES-D)
Time Frame: Change in depression symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks)
Self-report measure used to assess depressive symptoms. Total scores range from 0 to 60 with higher scores indicating a higher level of depressive symptoms.
Change in depression symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks)
Interpersonal Needs Questionnaire (INQ)
Time Frame: Change in suicide vulnerability from baseline to post treatment (4 weeks) and one month follow up (8 weeks)
Self report measure of suicide vulnerability. Total scores range from 15 to 105, with higher scores indicating a higher vulnerability for suicide.
Change in suicide vulnerability from baseline to post treatment (4 weeks) and one month follow up (8 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 25, 2018

Primary Completion (Actual)

December 15, 2019

Study Completion (Actual)

December 15, 2019

Study Registration Dates

First Submitted

September 13, 2018

First Submitted That Met QC Criteria

September 13, 2018

First Posted (Actual)

September 14, 2018

Study Record Updates

Last Update Posted (Actual)

January 29, 2021

Last Update Submitted That Met QC Criteria

January 26, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2018.23774

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Anxiety

Clinical Trials on Building Closer Friendships

Subscribe